Seeking Alpha

Watson Pharmaceuticals (WPI) agrees to buy Ascent Pharmahealth for A$375M ($396M), turning...

Watson Pharmaceuticals (WPI) agrees to buy Ascent Pharmahealth for A$375M ($396M), turning Watson into the fifth-largest generic pharmaceuticals firm in Australia and the largest in Singapore, while giving the company footholds in Malaysia, Hong Kong, Vietnam and Thailand. The deal will be immediately accretive to 2012 earnings.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|